PACS
Financial ServicesPACS Group, Inc. · Financial - Conglomerates · $6B
What is PACS Group, Inc.?
PACS Group, Inc. is a holding company focused on post-acute healthcare, operating facilities and ancillary services across senior care, assisted living, and independent living segments. Headquartered in Farmington, Utah, the company has grown rapidly since its founding.
PACS Group generates revenue by operating post-acute care facilities and providing healthcare professionals and ancillary services to patients transitioning out of hospital settings. The company serves seniors through skilled nursing facilities, assisted living communities, and independent living options. Its business model centers on facility operations and the delivery of coordinated care services, positioning it within the broader post-acute and senior care market.
PACS Group was founded in 2013 by Jason Murray and Mark Hancock and is headquartered in Farmington, Utah.
- Skilled nursing and post-acute care facilities
- Assisted living community operations
- Independent living residential services
- Ancillary healthcare professional staffing
- Senior care coordination services
Is PACS a Good Stock to Buy?
UQS Score rates PACS as Below Average overall, reflecting a mixed profile across its five quality pillars.
The Growth pillar stands out as the clearest bright spot — PACS has demonstrated an expansion trajectory that ranks among the stronger performers in its peer group. Valuation is also rated Good, suggesting the market may not be fully pricing in the company's growth runway relative to current fundamentals.
The Moat and Risk pillars are both rated Weak, indicating limited competitive differentiation and meaningful exposure to operational or financial vulnerabilities. The Quality pillar sits at Neutral, offering little additional cushion.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does PACS pay dividends?
No — PACS Group, Inc. does not currently pay a dividend.
PACS Group does not currently pay a dividend. For a company in a high-growth phase within the post-acute care sector, this is common — available capital is typically directed toward facility expansion, acquisitions, and operational scaling rather than shareholder distributions. Income-focused investors should factor this into their assessment.
When does PACS report earnings?
PACS Group reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's Growth pillar rating reflects a pattern of meaningful top-line expansion, though Risk factors remain a consideration when evaluating the sustainability of that trajectory. Profitability metrics and operational leverage are areas worth monitoring quarter to quarter.
For the most recent quarter's results and guidance, visit PACS Group's official investor relations page.
PACS Price History
+43.8% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in PACS Group, Inc.?
Based on PACS Group, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
PACS Long-term Outlook
PACS Group's Strong Growth pillar points to a business still in an expansion phase, with facility count and revenue scale likely to increase over the near term. However, the Weak Risk pillar introduces uncertainty around execution, leverage, or regulatory exposure that could temper that trajectory. The Good Valuation label suggests the current price may offer a reasonable entry relative to growth potential, but the Weak Moat rating means competitive pressures could erode returns over time.
Growth drivers
- Continued expansion of post-acute and senior care facility footprint
- Aging US population driving structural demand for skilled nursing services
- Ancillary service revenue growth alongside facility scale
Key risks
- Weak moat leaves the business exposed to pricing pressure from larger operators
- Regulatory and reimbursement changes in the post-acute care sector
- Elevated risk profile may signal balance sheet or operational vulnerabilities
PACS vs Peers
PACS Group operates in a space where it is sometimes grouped with diversified financial and infrastructure holding companies, though its core business is distinctly healthcare-focused.
Brookfield Infrastructure focuses on large-scale infrastructure assets globally, offering a very different risk and income profile compared to PACS's healthcare facility operations.
Voya Financial operates in retirement, investment, and insurance services — a financial services model with more diversified revenue streams than PACS's facility-centric approach.
Morgan Stanley Direct Lending Fund is a credit-focused vehicle targeting private middle-market companies, contrasting sharply with PACS's direct healthcare operations model.
Frequently Asked Questions
What does PACS Group do?
PACS Group is a holding company that operates post-acute healthcare facilities and provides senior care services. Its portfolio includes skilled nursing facilities, assisted living communities, and independent living options, along with ancillary healthcare staffing and coordination services across select US markets.
Does PACS pay dividends?
PACS Group does not currently pay a dividend. The company appears to be in a growth-oriented phase, directing capital toward facility expansion and operational development rather than shareholder distributions. Investors seeking income should consider this when evaluating the stock.
When does PACS report earnings?
PACS Group follows a standard quarterly earnings cadence for US-listed companies. For the most current reporting schedule and recent results, check the investor relations section of the company's official website.
Is PACS a good stock to buy?
The UQS Score rates PACS as Below Average overall. While the Growth pillar is Strong and Valuation is Good, the Weak Moat and Weak Risk ratings introduce meaningful concerns. Whether it suits your portfolio depends on your risk tolerance and investment horizon — the full pillar breakdown is available to Pro members.
Is PACS overvalued?
The UQS Valuation pillar for PACS is rated Good, suggesting the stock does not appear significantly overpriced relative to its fundamentals at the time of scoring. However, valuation should always be weighed alongside the company's risk profile and competitive positioning.
How does PACS compare to its competitors?
PACS Group's listed peers — Brookfield Infrastructure, Voya Financial, and Morgan Stanley Direct Lending — operate in very different business models. PACS is distinctly a post-acute healthcare operator, while its comparables span infrastructure and financial services. Direct operational comparisons are limited by these structural differences.
What is PACS's market cap bracket?
PACS Group is classified as a mid-cap company. This places it in a tier that typically offers more growth potential than large-caps but may carry greater volatility and liquidity considerations than mega-cap peers.
Who founded PACS Group?
PACS Group was founded in 2013 by Jason Murray and Mark Hancock. The company is headquartered in Farmington, Utah, and has grown its post-acute care footprint significantly since inception.
Is PACS a long-term quality investment?
From a long-term quality standpoint, PACS's UQS profile presents a mixed picture. The Strong Growth pillar is encouraging, but the Weak Moat rating suggests limited durable competitive advantage — a key factor for sustained long-term returns. The full analysis, including Quality and Risk detail, is available to Pro members.
What is the main competitive advantage of PACS Group?
Based on the UQS Moat pillar rating of Weak, PACS Group does not appear to have a strongly differentiated competitive position at this time. Its growth trajectory may reflect market expansion rather than a deeply entrenched structural advantage over peers in the post-acute care space.
What sector does PACS belong to?
PACS Group is classified under the Financial Services sector for scoring purposes, though its core operations are firmly in post-acute and senior healthcare services. This sector classification can affect how the company's metrics are benchmarked against peers.
Is PACS a growth stock or value stock?
PACS leans toward the growth side of the spectrum — its UQS Growth pillar is rated Strong, indicating above-average expansion. The Valuation pillar is rated Good, meaning it is not priced at a steep premium. This combination may appeal to investors seeking growth without extreme valuation risk.
Unlock Full PACS Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete five-pillar UQS Score breakdown
- ✓Access detailed financial metrics and trend data
- ✓Compare PACS against sector peers side by side
- ✓See Risk and Moat pillar detail behind the rating
- ✓Get the full analyst-grade quality assessment
- ✓Track score changes as new data is released
Pro Analysis
PACS — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | 48.5 | 45.8 | 24.0 | 82.1 | 31.8 | 65.5 | +6.9 |
| May 8, 2026 | 41.6 | 7.3 | 24.0 | 83.6 | 30.4 | 83.2 | -3.4 |
| May 7, 2026 | 45.0 | 40.1 | 24.0 | 83.6 | 15.2 | 66.7 | -0.1 |
| May 3, 2026 | 45.1 | 40.1 | 24.0 | 83.6 | 15.2 | 67.5 | +0.3 |
| Apr 26, 2026 | 44.8 | 40.1 | 24.0 | 83.6 | 15.2 | 65.4 | -0.1 |
| Apr 19, 2026 | 44.9 | 40.1 | 24.0 | 83.6 | 15.2 | 65.6 | -0.2 |
| Apr 18, 2026 | 45.1 | 40.1 | 24.0 | 83.6 | 15.2 | 67.0 | -2.5 |
| Apr 14, 2026 | 47.6 | 40.1 | 24.0 | 83.6 | 15.2 | 83.8 | +0.1 |
| Apr 12, 2026 | 47.5 | 40.1 | 24.0 | 83.6 | 15.2 | 83.5 | -0.3 |
| Apr 11, 2026 | 47.8 | 40.1 | 24.0 | 83.6 | 15.2 | 85.3 | -0.1 |
PACS — Pillar Breakdown
Quality
— 46.3/100 (25%)PACS Group, Inc. has average quality metrics, with room for improvement in margins or capital efficiency.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Free cash flow relative to market value.
Growth
— 82.1/100 (20%)PACS Group, Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 31.8/100 (15%)PACS Group, Inc. presents elevated risk with concerns around leverage or financial stability.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 66.3/100 (15%)PACS Group, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 24/100 (25%)PACS Group, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for PACS.
Score Composition
Financial Data
More Stock Analysis
How is the PACS UQS Score Calculated?
The UQS (Unified Quality Score) for PACS Group, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses PACS Group, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether PACS Group, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.